Appili Therapeutics Inc.
Infectious disease and biodefense therapeutics (small molecules and biologics in development)
- Sector
- Biotech
- Headquarters
- HALIFAX, A5
- Founded
- 2015
- Latest Form D
- $3.5M, Sep 2021
- Total capital
- $4.5M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $4.5M
- 3 Form D · last Sep 2021
- 62 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 2
- 1 pending · first 2023
- Rank in peer group#397 of 1449
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 3rd filing$3.5M
- Private capital raisedForm D · SEC · 2nd filing$1M
- Private capital raisedForm D · SEC · 1st filing$15K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 1449 peers
Line = medianBiotech · Molecule
- Granted patents#397 · top 27%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- ARMAND C BALBONIExecutive Officer, DirectorNamed in SEC Form D filings
- BRIAN M. BLOOMDirectorNamed in SEC Form D filings
- IAN C MORTIMERDirectorNamed in SEC Form D filings
- John HolyoakeExecutive Officer, DirectorNamed in SEC Form D filings
- JUERGEN C. FROEHLICHDirectorNamed in SEC Form D filings
- Kevin SullivanExecutive Officer, DirectorNamed in SEC Form D filings
Show all 10 people
- Kimberly StephensExecutive OfficerNamed in SEC Form D filings
- Lidija MarusicDirectorNamed in SEC Form D filings
- ROCHELLE C. STENZLERDirectorNamed in SEC Form D filings
- THERESA C MATKOVITSDirectorNamed in SEC Form D filings
What it has protected
USPTO · 2 granted of 3- GrantedOral Formulations Of Metronidazole And Methods Of Treating An Infection Using SameUSPTOUS 12,257,236
- GrantedOral Formulations Of Metronidazole And Methods Of Treating An Infection Using SameUSPTOUS 11,541,035
- PendingComposition And Method For Treating Candida Auris InfectionUSPTOApplication 17735144
Related companies, and why
- Meditope Biosciences, Inc.Similar federal contract value in Biotech · null in contracts
- Providence Therapeutics Inc.Similar federal contract value in Biotech · null in contracts
- Gene Sciences, Inc.Similar federal contract value in Biotech · null in contracts
- Sift Biosciences, Inc.Similar federal contract value in Biotech · null in contracts
- OneSkin, Inc.Similar federal contract value in Biotech · null in contracts
- Xcell Biosciences, Inc.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .